Press Releases
 
Antidiabetics Market Research Explores The Key Success Factors, And Business Opportunities Including

, 25 June 2019 -- Antidiabetics Market with Top Business Growing Strategies, Technological Innovation And Emerging Trends Of Outlook To 2015 - 2023

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.

View Report: https://www.transparencymarketresearch.com/antidiabetics-market.html

The anti-diabetics market has been segmented based on type of drug class into biguanides (metformin), sulfonylureas (glimepiride), meglitinides (repaglinide), thiazolidinediones (pioglitazone), dipeptidyl peptidase IV (DPP-IV) inhibitors (sitagliptin), and α-glucosidase inhibitors (acarbose).

Among these drug classes, Biguanides act directly against insulin resistance. Sulfonylureas (SUs) were the earliest drug classes in the market for treatment of diabetes and have a significant market presence. α-glucosidase inhibitors delay postprandial glucose absorption by hydrolysis of disaccharide is into monosaccharide’s in the small intestine. Meglitinides are prandial insulin releasers that stimulate rapid insulin secretion. The thiazolidinediones are insulin-sensitizing drugs, which improve whole-body insulin sensitivity through gene regulation. DPP-IV inhibitors make a significant impact on glucose tolerance and make lasting improvements in the health outcomes of diabetic patients.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8809

Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk’s diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk.

However, despite the availability of numerous branded antidiabetic drugs, many of these drugs have lost patent protection. In the wake of huge pressures from government and regulatory authorities, which have banned top selling drugs in various countries, in order to promote generic drugs at lower costs for diabetic patients. For instance, Mankind Pharma, launched anti-diabeticDynaglipt (Teneligliptin) under the drug class DPP-4 inhibitors in November 2015 in India targeting the middle to low income diabetic patient population.

As a result, the volume of antidiabetics is expected to shift to first generation drugs and other generic drugs in the market. Moreover, there is a huge unmet medical need for antidiabetics that can treat multiple chronic disorderscoexisting with diabetessuch as cardiovascular diseases, dyslipidemia, hypertension etc. Another major restraint in the antidiabetics market is reduction in the efficacy of drugs over a period and canlead to other health complications.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=8809

Some of the major players in the market include Astra Zeneca plc, Boehringer Ingelheim GmbH, Eli Lilly & Co., Johnson & Johnson, Mankind Pharma Ltd., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., and Teva Pharmaceutical Industries Ltd.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Tuesday, 25 June 2019 at 8:51 PM
Category: Health Care & Medical
 
Related News

Probiotic Company Plans to Attend Major Expo
Sunday, 21 Jul 2019

Learn How Root Canal Specialist Can Help You
Sunday, 21 Jul 2019

Hepatitis Therapeutics Market Review with Forecast Research Report 2018 - 2026
Saturday, 20 Jul 2019

Cranial & Auricular Electrostimulation Devices Market Scope and Opportunities Analysis 2018 –
Saturday, 20 Jul 2019

Compounding Pharmacy Market Growth and Sales Forecast 2018 - 2026
Saturday, 20 Jul 2019

Related Events

Oncology Review
Saturday, 20 Jul 2019

Breast Imaging A to Z: How to Read Like (or Better Than) the Experts-Hawaii
Monday, 22 Jul 2019

Update in Orthpaedic Surgery Conference July 22-25, 2019 Grand Hyatt Kauai
Monday, 22 Jul 2019

Echocardiographic Symposium at Vail
Monday, 22 Jul 2019

Microbiome Movement - Oncology Response Summit
Monday, 22 Jul 2019

Latest News

Time to Use Safe, Satisfying, and Stable Herbal Ingredients!
Sunday, 21 Jul 2019

Marriage Counseling Suggestions
Sunday, 21 Jul 2019

Saudi Arabia to Organize World PEACE Products and services Expo to Reconstruct the Global Peace Prod
Sunday, 21 Jul 2019

Probiotic Company Plans to Attend Major Expo
Sunday, 21 Jul 2019

Rock Down the River This Summer
Sunday, 21 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Sunday, 21 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Oncology Review
  • Breast Imaging A to Z: How to Read Like (or Better Than) the Experts-Hawaii
  • Update in Orthpaedic Surgery Conference July 22-25, 2019 Grand Hyatt Kauai
  • Echocardiographic Symposium at Vail
  • Microbiome Movement - Oncology Response Summit

  • Latest Jobs
    Sorry, there are currently no entries posted here.